Stanley-Laman Group, Ltd. - TARO PHARMACEUTICAL INDS LTD ownership

TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 103 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q2 2015. The put-call ratio across all filers is 0.74 and the average weighting 1.1%.

Quarter-by-quarter ownership
Stanley-Laman Group, Ltd. ownership history of TARO PHARMACEUTICAL INDS LTD
ValueSharesWeighting
Q1 2016$519,000
-84.3%
3,625
-83.1%
0.10%
-82.7%
Q4 2015$3,315,000
+10.1%
21,447
+1.7%
0.57%
-7.3%
Q3 2015$3,012,000
-9.6%
21,080
-9.1%
0.61%
+0.5%
Q2 2015$3,331,00023,1800.61%
Other shareholders
TARO PHARMACEUTICAL INDS LTD shareholders Q2 2015
NameSharesValueWeighting ↓
HealthInvest Partners AB 78,905$8,306,0007.65%
FORT, L.P. 157,584$16,589,0004.68%
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 808,200$85,079,0004.39%
Strategic Global Advisors, LLC 81,432$8,572,0003.18%
Prince Street Capital Management LLC 48,700$5,127,0001.62%
Analyst IMS Investment Management Services Ltd. 31,438$3,309,0001.45%
Freestone Capital Holdings, LLC 84,900$8,937,0000.77%
RPG Investment Advisory, LLC 17,227$1,813,0000.61%
CLINTON GROUP INC 46,370$4,881,0000.28%
USA FINANCIAL FORMULAS 10,786$1,135,0000.28%
View complete list of TARO PHARMACEUTICAL INDS LTD shareholders